Synthesis of novel mono- and bis-pyrazolylthiazole derivatives as anti-liver cancer agents through EGFR/HER2 target inhibition
Abstract 3-Bromoacetyl-4-(2-naphthoyl)-1-phenyl-1H-pyrazole (6) was synthesized from 2-acetylnaphthalene and was used as a new key building block for constructing the title targets. Thus, the reaction of 6 with the thiosemicarbazones 7a–d and 9–11 afforded the corresponding simple naphthoyl-(3-pyraz...
Main Authors: | Mostafa E. Salem, Esraa M. Mahrous, Eman A. Ragab, Mohamed S. Nafie, Kamal M. Dawood |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-06-01
|
Series: | BMC Chemistry |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13065-023-00921-6 |
Similar Items
-
Expression of EGFR isoform D is regulated by HER receptor activators in breast cancer cells
by: Lisandra Negrón-Vega, et al.
Published: (2022-09-01) -
Synthesis and Anti-Breast Cancer Potency of Mono- and Bis-(pyrazolyl[1,2,4]triazolo[3,4‑b][1,3,4]thiadiazine) Derivatives as EGFR/CDK‑2 Target Inhibitors
by: Mostafa E. Salem, et al.
Published: (2023-09-01) -
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
by: Diana B. Peckys, et al.
Published: (2021-11-01) -
Benzo[g]quinazolin-based scaffold derivatives as dual EGFR/HER2 inhibitors
by: Mostafa M. Ghorab, et al.
Published: (2018-01-01) -
Notch-EGFR/HER2 Bidirectional Crosstalk in Breast Cancer
by: Andrew T Baker, et al.
Published: (2014-12-01)